BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15272534)

  • 21. The binding of thyroid transcription factor-1 and hepatocyte paraffin 1 to mitochondrial proteins in hepatocytes: a molecular and immunoelectron microscopic study.
    Pang Y; von Turkovich M; Wu H; Mitchell J; Mount S; Taatjes D; Cooper K
    Am J Clin Pathol; 2006 May; 125(5):722-6. PubMed ID: 16707373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
    Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
    J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous metastasis of hepatocellular carcinoma diagnosed by fine needle aspiration cytology and Hep Par 1 immunopositivity.
    Isa NM; Bong JJ; Ghani FA; Rose IM; Husain S; Azrif M
    Diagn Cytopathol; 2012 Nov; 40(11):1010-4. PubMed ID: 21563319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma.
    Mac MT; Chung F; Lin F; Hui P; Balzer BL; Wang HL
    Am J Clin Pathol; 2009 Jul; 132(1):80-5. PubMed ID: 19864237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma presenting as a precocious cutaneous metastasis.
    Royer MC; Rush WL; Lupton GP
    Am J Dermatopathol; 2008 Feb; 30(1):77-80. PubMed ID: 18212552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytodiagnosis of neoplastic metastases to the liver. Immunocytochemical studies.
    Tomaszewska R; Stachura J
    Pol J Pathol; 1994; 45(2):145-53. PubMed ID: 8062066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma.
    Wieczorek TJ; Pinkus JL; Glickman JN; Pinkus GS
    Am J Clin Pathol; 2002 Dec; 118(6):911-21. PubMed ID: 12472285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoma of unknown primary: check the liver... thanks to TTF-1.
    Mishra M; Morgan V; Hamati AK; Al-Abbadi M
    Tenn Med; 2012 Jan; 105(1):35-6, 40. PubMed ID: 22359993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous metastases of hepatocellular carcinoma.
    Lazaro M; Allende I; Ratón JA; Acebo E; Diaz-Perez JL
    Clin Exp Dermatol; 2009 Dec; 34(8):e567-9. PubMed ID: 19489869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical characterization of canine intestinal epithelial and mesenchymal tumours with a monoclonal antibody to hepatocyte paraffin 1 (Hep Par 1).
    Ramos-Vara JA; Miller MA
    Histochem J; 2002; 34(8-9):397-401. PubMed ID: 12814187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B; Boub R; Rahsaz M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.
    Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML
    J Natl Cancer Inst; 2005 Jun; 97(11):836-45. PubMed ID: 15928304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of metastatic cutaneous nodules of recurrent hepatocellular carcinoma].
    Cho M; Choi CS; Seo GS; Kim TH; Choi SC; Yun KJ; Kim HC
    Korean J Hepatol; 2007 Jun; 13(2):234-8. PubMed ID: 17585197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunohistochemical spectrum in the detection and differentiation of intrahepatic neoplasms].
    Cong W; Tan L; Zhang S; Xian Z; Wu W; Pan J; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):553-6. PubMed ID: 12667323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous metastases from hepatomas.
    Reingold IM; Smith BR
    Arch Dermatol; 1978 Jul; 114(7):1045-6. PubMed ID: 210712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
    Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
    J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody MOC-31 reactivity as a marker for adenocarcinoma in cytologic preparations.
    Hecht JL; Pinkus JL; Pinkus GS
    Cancer; 2006 Feb; 108(1):56-9. PubMed ID: 16329115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review.
    Lamps LW; Folpe AL
    Adv Anat Pathol; 2003 Jan; 10(1):39-43. PubMed ID: 12502967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.
    Zimmerman RL; Burke MA; Young NA; Solomides CC; Bibbo M
    Cancer; 2001 Aug; 93(4):288-91. PubMed ID: 11507703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.